Search research articles
Contact Us
Filters
Showing results (131-140 of 411) with videos related to
Page
of 42
Sort By:
Brain Research. Brain Research Protocols
|
March 30, 2005
Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects
Arun L W Bokde, Stefan J Teipel, Robert Schwarz, et al.
Archives of General Psychiatry
|
June 6, 2007
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Zhenyu Zhong, Michael Ewers, Stefan Teipel, et al.
Journal of Neuroimmunology
|
March 9, 2010
Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation
Andrea Ernst, Katharina Buerger, Oliver Hartmann, et al.
Frontiers in Neuroendocrinology
|
June 15, 2018
Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification
Harald Hampel, Andrea Vergallo, Filippo Sean Giorgi, et al.
Neurobiology of Aging
|
May 2, 2017
Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment
Thomas Jacquemont, Fabrizio De Vico Fallani, Anne Bertrand, et al.
Journal of Alzheimer'S Disease : JAD
|
January 5, 2012
Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease
Alexander Navarrete Santos, Michael Ewers, Lennart Minthon, et al.
Progress in Neurobiology
|
July 2, 2011
Staging Alzheimer's disease progression with multimodality neuroimaging
Michael Ewers, Giovanni B Frisoni, Stefan J Teipel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 15, 2011
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Manfred Gerlach, Walter Maetzler, Karl Broich, et al.
Neurobiology of Aging
|
November 7, 2016
The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster
Sabrina Pichler, Wei Gu, Daniela Hartl, et al.
Brain : a Journal of Neurology
|
June 25, 2003
Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity
Yansheng Du, Xing Wei, Richard Dodel, et al.
Page
of 42
Search research articles
Search
Showing results (131-140 of 411) with videos related to
Sort By:
Page
of 42
Brain Research. Brain Research Protocols
|
March 30, 2005
Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects
Arun L W Bokde, Stefan J Teipel, Robert Schwarz, et al.
Archives of General Psychiatry
|
June 6, 2007
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Zhenyu Zhong, Michael Ewers, Stefan Teipel, et al.
Journal of Neuroimmunology
|
March 9, 2010
Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation
Andrea Ernst, Katharina Buerger, Oliver Hartmann, et al.
Frontiers in Neuroendocrinology
|
June 15, 2018
Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification
Harald Hampel, Andrea Vergallo, Filippo Sean Giorgi, et al.
Neurobiology of Aging
|
May 2, 2017
Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment
Thomas Jacquemont, Fabrizio De Vico Fallani, Anne Bertrand, et al.
Journal of Alzheimer'S Disease : JAD
|
January 5, 2012
Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease
Alexander Navarrete Santos, Michael Ewers, Lennart Minthon, et al.
Progress in Neurobiology
|
July 2, 2011
Staging Alzheimer's disease progression with multimodality neuroimaging
Michael Ewers, Giovanni B Frisoni, Stefan J Teipel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 15, 2011
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Manfred Gerlach, Walter Maetzler, Karl Broich, et al.
Neurobiology of Aging
|
November 7, 2016
The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster
Sabrina Pichler, Wei Gu, Daniela Hartl, et al.
Brain : a Journal of Neurology
|
June 25, 2003
Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity
Yansheng Du, Xing Wei, Richard Dodel, et al.
Page
of 42